Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
268.3 USD | -4.16% | -2.12% | -16.92% |
05-08 | UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating | MT |
05-08 | RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.92% | 7.98B | |
-4.66% | 185B | |
-1.01% | 109B | |
-4.20% | 68.54B | |
+2.68% | 51.74B | |
+9.12% | 45.22B | |
+3.83% | 41.74B | |
+4.13% | 26.83B | |
+3.31% | 26.69B | |
+13.67% | 25.63B |
- Stock Market
- Equities
- BIO Stock
- News Bio-Rad Laboratories, Inc.
- Earnings Flash (BIO.B) BIO-RAD LABORATORIES Posts Q4 Revenue $681.2M, vs. Street Est of $686.6M